View all trials
Are you a member? Sign in above to view additional information
  • Study title
    International Randomised Phase III Clinical Trial in Children with Acute Myeloid Leukaemia - Incorporating an Embedded Dose Finding Study for Gemtuzumab Ozogamicin in Combination with Induction Chemotherapy
  • Protocol ID
    MyeChild-01 (RG_14-088)
  • Disease
    Disease Type Disease Subtype
    Leukaemia
    AML
  • Eligibility criteria
  • Study Status
    Open
  • Location(s)
    Children's Hospital at Westmead
    • Centre Study Status:
      Open
    • Notes:
    Lady Cilento Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
    Perth Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
  • Phase
    Phase 3
  • Study type
    Treatment
  • Diagnosis stage
    New diagnosis
  • Study open date
    04/07/2018
  • Study close date
    N/A
  • Study chair
    Dr Andy Moore
  • Sponsor
    University of Birmingham
Back to search results